Researchers uncover potential new biomarker for psychosis diagnosis

The current standard of care for psychosis is a diagnostic interview, but what if it could be diagnosed before the first symptom emerged? Researchers at the Del Monte Institute for Neuroscience at the University of Rochester are pointing toward a potential biomarker in the brain that could lead to more timely interventions and personalized care.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup